Skip to main content
Menu
eyeexammag
Home »

Author: northyorkeyeclinic

*NEW* ALCON – PRECISION1 ONE DAY CONTACT LENSES

Alcon Canada Alcon Canada introduces PRECISION1  Contact Lenses

 

NEW PRECISION1 ONE DAY CONTACT LENSES

PRECISION1® daily contact lenses provide lasting visual performance and comfort, through the use of SMARTSURFACE Technology – a permanent, micro-thin layer of moisture for greater than 80% lens surface water content. They’re made with verofilcon A material with Class I UV-blocking capabilities to absorb more than 90% of UVA and 99% of UVB. PRECISION1 is the first mainstream daily disposable contact lens to use SMARTSURFACE Technology to deliver lasting visual performance and comfort.

“PRECISION1 is designed to provide lasting visual performance for patients who wear their contact lenses from early morning to late at night,” said David Endicott, Chief Executive Officer, Alcon. “PRECISION1 will be well-positioned as a mainstream daily disposable that complements our premium DAILIES TOTAL1®and value-driven DAILIES®AquaComfort PLUS®contact lenses, further expanding our contact lens portfolio to give us long-term growth opportunities in 2020 and beyond as we continue to develop our promising pipeline.”

PRECISION1 was designed to address the common reasons why 1-in-5 new wearers discontinue contact lens wear within the first year: poor vision, poor comfort and handling issues. The lenses help new daily disposable contact lens wearers overcome these issues by providing precise vision, long-lasting comfort and ease of handling. It also introduces a new lens material – verofilcon A with Class 1 ultraviolet-blocking capabilities (the highest level available) – created specifically for PRECISION1 by Alcon Research and Development.

 

*NEW* Bausch + Lomb ULTRA Multifocal for Astigmatism Contact Lenses

To enhance the contact lens wearing experience and address these needs, Bausch + Lomb ULTRA Multifocal for Astigmatism contact lenses, the most advanced soft contact lens design in the history of Bausch + Lomb, have been engineered for maximized wearing comfort, exceptional visual clarity and stability and efficient fitting. The lens offers a complete package of toric and multifocal advancements with the seamless transition of the company’s 3-Zone Progressive design and the stability offered from the OpticAlign design with MoistureSeal® technology.

Bausch + Lomb ULTRA Multifocal for Astigmatism contact lenses were designed to reduce these traditional barriers to lens wear by offering an easy-to-fit, multifocal toric lens.

Bausch + Lomb Ultra Multifocal for Astigmatism to provide patients a lens with excellent comfort and vision that can be fit during the initial contact lens exam.

The majority of all adults ages 40 or older currently wear some type of vision correction, with nearly one-third of those being astigmatic. Previously, eye care professionals who decided to move forward with a multifocal toric lens fitting for these patients were unable to do so during the initial visit. They were required to special order the lenses and schedule a follow-up appointment for a fitting. With Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses, eye care professionals will have the ability to immediately fit patients with these lenses as a standard offering in the fitting set. Bausch + Lomb Ultra Multifocal for Astigmatism lenses will not only deliver on these benefits by providing these patients a same-day fitting option that addresses their presbyopia and astigmatism, but also a unique differentiator in my practice with the reliability of a trusted brand.

 

blultrajpeg

Acuvue Oasys “TRANSITIONS” contact lenses are now available at North York Eye Clinic

North York Eye Clinic is proud to announce a new revolutionary contact lens from Johnson & Johnson Vision Care called Acuvue Oasys Transitions Contact Lenses. Based on the Acuvue Oasys material, it is also a two week disposable contact lens.

The revolutionary Acuvue Oasys with Transitions Light Intelligent Technology lenses experience fits the bill, thanks to a dynamic photochromic filter that responds to changing light conditions—indoors and out—by reducing exposure to bright light, filtering out blue light, blocking UV rays and, of course, providing vision correction at the same time.

Call the office at 647-352-5553 to book a contact lens fitting at North York Eye Clinic.

jnjactra

acuvue oasys 433x337 actra2

 

MiSight® 1 day by CooperVision for Myopia Control

 

MiSight packshot

 

https://www.prnewswire.com/news-releases/coopervision-releases-four-year-data-on-landmark-misight-1-day-contact-lens-study-pioneering-approach-slows-myopia-progression-in-children-300713073.html

CooperVision Releases Four-Year Data on Landmark MiSight® 1 Day Contact Lens Study; Pioneering Approach Slows Myopia Progression in Children

– Latest data from the Clinical Evaluation of a Dual-Focus Myopia Control 1-Day Soft Contact Lens Study shared during the BCLA Asia Conference and Exhibition in Singapore

– Innovative approach continues to substantially slow myopia progression and eye elongation among children continuing to wear the MiSight® contact lens in year four

– Switching control group into MiSight® during the latest year demonstrates the technology also benefits older children


NEWS PROVIDED BY

CooperVision

Sep 17, 2018, 19:00 ET

 


SINGAPORE, Sept. 17, 2018 /PRNewswire/ — New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later. CooperVision is presenting the multi-year study’s latest outcomes during the BCLA Asia conference in Singapore this week, at which the globally increasing prevalence of myopia is among the most widely discussed issues.

The ongoing clinical trial is assessing a specially-designed, dual-focus myopia control 1-day soft contact lens in reducing the rate of progression of juvenile-onset myopia. The lens is commercially available as CooperVision® MiSight® in select countries.1

“Four-year results on the efficacy of our innovative myopia control lens represent a landmark in slowing myopia progression. The treatment is continuing to work for children who have been wearing MiSight® contact lenses for the entire study, and their axial length progression in this last year has slowed further. This illustrates the benefits of beginning myopia management as early as possible to maximize the benefit,” said Paul Chamberlain, Director of Research Programs for CooperVision.

After year three, myopia progression slowed in children wearing the MiSight® contact lens: 59% as measured by mean cycloplegic spherical equivalent (SE) and 52% as measured by mean axial elongation of the eye when compared to the children in the control group wearing a single vision 1-day contact lens.

In year four, children in the original control group were refit with the myopia control lens, and then continued to be tracked separately. Use of the dual-focus contact lens — which has alternating visual correction and treatment zones — was effective in slowing myopia progression in both groups:

  • There was a significant reduction in myopic progression for the previous single vision 1-day wearers, indicating that MiSight® contact lenses are also effective when beginning myopia management at an older age.
  • There were no significant differences between groups for change in Spherical Equivalent Refractive Error and Axial Length over 12 months.
  • Axial length growth of 0.07mm in the MiSight® group and 0.06mm in the previous control group, compared to 0.10mm seen in the MiSight® group in year three, represents further myopia slowing as the children age.
  • There were no significant differences in myopia progression rates for two demographically matched populations in their first versus fourth years of MiSight® contact lens wear.

No other prospective randomized controlled study has offered conclusive data for such a high degree of continued efficacy in myopia management using a 1-day soft contact lens over four years. The contact lens-based approach does not induce common side effects exhibited by some alternative pharmacological therapies.

The prevalence of myopia is projected to increase from approximately two billion people worldwide in 2010 to almost five billion people in 20502, bringing with it near- and long-term health challenge Not only does it create blurred vision, but also increases the likelihood of conditions later in life such as glaucoma, cataract, retinal detachment and myopic maculopathy if not addressed.

“The four-year results are another great learning for CooperVision and the entire optical industry on the capability to slow the progression of myopia in children. Though children benefit at whatever age the treatment is started, the sooner their myopia is managed with MiSight® contact lenses, the more effect and benefit they receive in reducing final levels and the future risk of related vision impairment issues,” said Stuart Cockerill, Senior Director, Myopia Management.

Physiological changes among 100 myopic children from Singapore, Canada, England, and Portugal were evaluated during the fourth year.

1 MiSight® 1 day contact lenses are currently available for sale in Canada, the United Kingdom, France, Spain, Portugal, Netherlands, Germany, Austria, Switzerland, the Nordic Region, Singapore, Malaysia, Hong Kong, Australia and New Zealand. MiSight® is not approved in the United States.2 Holden et al, Ophthalmology 2016.

About CooperVision CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit coopervision.com.

About The Cooper Companies The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, Calif., Cooper has more than 12,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Media ContactMike McDougall, APR, Fellow PRSAMcDougall Communications for CooperVision, Inc. mike@mcdougallpr.com or +1-585-434-2150

SOURCE CooperVision

Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact Lenses

ULTRA MFT FF 2018 NL

Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact Lenses

Bausch + Lomb announced that it has received FDA 510(k) clearance for Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses, the company’s first multifocal toric lens to be available as a standard offering.

Bausch + Lomb says the monthly silicone hydrogel lens is the company’s most advanced soft contact lens design.

“Eye care professionals have routinely stressed the need to have a readily available contact lens that addresses both presbyopia and astigmatism, underscoring the critical vision needs of this growing patient population,” Joe Gordon, U.S. president, Bausch + Lomb, said in a company news release. “Our in-house team of scientists and contact lens designers developed Bausch + Lomb Ultra Multifocal for Astigmatism to provide patients a lens with excellent comfort and vision that can be fit during the initial contact lens exam. We anticipate Bausch + Lomb Ultra Multifocal for Astigmatism will be available to eye care professionals and their patients by mid-2019.”

The majority of all adults ages 40 or older currently wear some type of vision correction, with nearly one-third of those being astigmatic. Previously, eye care professionals who decided to move forward with a multifocal toric lens fitting for these patients were unable to do so during the initial visit. They were required to special order the lenses and schedule a follow-up appointment for a fitting. With Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses, eye care professionals will have the ability to immediately fit patients with these lenses as a standard offering in the fitting set.

“As the population of astigmatic patients with presbyopia grows, the availability of a comfortable and convenient option to help this population of patients is critical,” said Gina Wesley, OD, Complete Eye Care of Medina, Minnesota. “I believe these new Bausch + Lomb Ultra Multifocal for Astigmatism lenses will not only deliver on these benefits by providing these patients a same-day fitting option that addresses their presbyopia and astigmatism, but also a unique differentiator in my practice with the reliability of a trusted brand.”

ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ Named in TIME’s ‘Best Inventions of 2018’

acuvue oasys transitions logo

https://www.newswire.ca/news-releases/acuvue-oasys-with-transitions-light-intelligent-technology-named-in-times-best-inventions-of-2018-700709662.html

 

PINELLAS PARK, Fla., Nov. 16, 2018 /CNW/ — TIME has selected ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ as one of the ‘Best Inventions of 2018,’ in its annual round-up spotlighting groundbreaking innovations worldwide. Developed through a strategic partnership between Johnson & Johnson Vision and Transitions Optical, an Essilor International Company, this innovation represents an entirely new category of contact lenses that provides wearers with vision correction and reduces blaring lightii,iii for all-day soothing vision.iv,v

ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ – built for a modern and active lifestyle – helps reduce exposure to bright light indoors and outdoors, including filtering blue lightvi and blocking UV rays that can impact eye comfort, vision and health.† ‡ vii,viii,ix,x,xi The lenses help the eyes manage different types of light at different intensities and brightness throughout the day. Combining the strengths and expertise of each company, the contact lens was born out of deep research into consumer lifestyle needs.

Transitions Optical has long been the leader in light management technology, mastering light for over 28 years. It has a long history of product innovations and strategic partnerships that have enabled the company to break new ground, grow the photochromic category and introduce the benefits of light adaptation to more patients. It took more than a decade to combine the revolutionary light-adaptive Transitions technology with these advanced contact lenses. The result are lenses that deliver a first-of-its-kind benefit, going beyond vision correction to be as nimble as consumers are in their everyday lives.

“We are very proud to see ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ selected by TIME magazine as one of the ‘Best Inventions of 2018’. This innovation will revolutionize contact lenses and photochromics by introducing the benefits of light adaptation to more patients,” said Chrystel Barranger, president of Essilor Photochromics and Transitions Optical. “Addressing the unmet needs of contact lens wearers, this innovation contributes to achieving our mission to bring good vision to each person on the planet.”

The two-week reusable contact lens, which will be marketed by Johnson & Johnson Vision Care, Inc., continuously adapts from clear to dark and back, helping eyes adjust to changing light better than they would on their own.viiACUVUE OASYS with Transitions begin to darken as soon as they’re exposed to UV or HEV light, thanks to Transitions Light Intelligent Technology, becoming dark in 45 seconds – and fade back from dark to clear within 90 seconds when going from outdoors to indoors.vii At full activation, the lenses block up to 70 percent of visible light and filters light indoors, even in its clearest state.vii The revolutionary invention is designed to offer the highest level of UV protection available in contact lenses and are the only contact lens that provides 100% protection against UVB rays. † ‡ vii, viii

The lenses received 510(k) clearance for the attenuation of bright light from the U.S. Food and Drug Administration in April of this year. They are expected to launch in the U.S. and other select markets in the first half of 2019.

About Transitions Optical Transitions Optical is the leading provider of photochromic (smart adaptive) lenses worldwide, having been the first to successfully manufacture and commercialize plastic adaptive lenses in 1990. As a result of its relentless investment in research, development and technology, Transitions Optical offers a wide variety of eyeglass lens and shield products, setting new standards of advanced performance to provide ever increasing visual comfort and optimum harmful blue light protection, and always blocking 100% of UVA and UVB rays.

Product leadership, consumer focus, and operational excellence have made the Transitions® brand one of the most recognized consumer brands in optics. For more information about the company and Transitions® Light Intelligent Technology™, visit Transitions.com or TransitionsPRO.com.

Transitions Optical is a fully owned subsidiary of Essilor International.

About Johnson & Johnson Vision At Johnson & Johnson Vision, we have a bold ambition: to change the trajectory of eye health around the world. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at www.jjvision.com. Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn.

Important Information for Contact Lens Wearers: ACUVUE® Brand Contact Lenses are only available by prescription for vision correction as a daily wear lens with a two-week recommended replacement. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, remove the lens and contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional and ask for a Patient Instruction Guide, call 1-800-843-2020 or visit Acuvue.com.

†Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

‡WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

ACUVUE OASYS® is a trademark of Johnson & Johnson Vision Care, Inc.

*NEW* ACUVUE OASYS® with Transitions® Light Intelligent Technology™

Johnson & Johnson Vision Announces Revolutionary Contact Lens Innovation with ACUVUE OASYS® with Transitions® Light Intelligent Technology™

Johnson & Johnson Vision today announced ACUVUE OASYS® with Transitions® Light Intelligent Technology™ first of its kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye. These contact lenses quickly and seamlessly adjust from clear to dark in response to changing light conditions; reducing exposure to bright light indoors and outdoors, including filtering blue light and blocking UV rays+ ‡.

 

Screen Shot 2018 05 30 at 3.58.42 PM Screen Shot 2018 05 30 at 3.58.32 PM

*NEW* Air Optix Colors Contact Lenses – 3 New Colors Are Available to Order: Amethyst, True Sapphire and Turquoise

Alcon Introduces AIR OPTIX® COLORS Contact Lenses Gemstone Collection, Creating New Ways to Enhance and Play with Eye Color

 

Alcon, the global leader in eye care and a division of Novartis, is launching the new AIR OPTIX® COLORS Gemstone Collection of contact lenses, a trio of colors including Amethyst, True Sapphire and Turquoise. The new color palette gives consumers more ways to experiment and play with their eye color to further enhance their look. At the same time, Alcon is introducing 2-packs of AIR OPTIX® COLORS contact lenses that are affordably priced to make it even more convenient to try different colors.

With the addition of the new Gemstone Collection, the full AIR OPTIX® COLORS contact lenses line now offers 12 color options to play with — including True Sapphire, Amethyst, Turquoise, Gray, Blue, Green, Pure Hazel, Brown, Sterling Gray, Brilliant Blue, Gemstone Green and Honey – to naturally enhance any eye color.

Screen Shot 2018 05 30 at 3.46.15 PM

Screen Shot 2018 05 30 at 3.45.59 PM

Zeiss – SNOW Goggles

High Quality Ski Goggles by Zeiss.

Available Zeiss Ski Goggles in a wide variety of colours and eye protection levels.

Please e-mail the offie at info@northyorkeyeclinic.com if you have any questions.

Screen Shot 2018 03 09 at 7.09.06 PMScreen Shot 2018 03 09 at 7.24.04 PM

x

We Are COVID Ready!